---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "Dementie en herinneringen"
developer_entity: "Amulet BV"
bundle_id: "com.irpulsar.dementie"
app_store_id: "1066720974"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Free"
offline_capable: false
market_region: "US"
platforms: "iOS"
app_last_updated: "2025-08-29"
report_date: "2026-08-15"
last_verified: "2026-08-15T00:00:00.000Z"
report_version: "5.0.1"
total_reviews: 0
confidence: "low"
confidence_score: 0.25
data_age_days: 86
momentum_velocity: "zombie"
intelligence_version: 3
tags: ["medical", "free", "mobile app", "app review", "app analysis", "healthcare", "professionals,", "informal"]
canonical_url: "https://marlvel.ai/apps/dementie-en-herinneringen"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# Dementie en herinneringen Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical · Free

> **TL;DR:** Dementie en herinneringen is a medical app by Amulet BV, available on iOS.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** Dementie en herinneringen is a medical app by Amulet BV.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Category** | Medical |
| **Developer** | Amulet BV |
| **Pricing** | Free |
| **Platforms** | iOS |
| **Confidence** | Low (0.25/1.0) |
| **Data Age** | 86d |

## Metadata & Market Performance
- **Publisher:** Amulet BV
- **Category:** Medical
- **Target Audience:** Healthcare professionals, informal caregivers, and family members supporting individuals with dementia.
- **Platforms:** iOS
- **Version Reviewed:** 5.0.1
- **Report Date:** 2026-08-15
- **Signal Count:** 0 reviews analyzed
- **Confidence:** Low (0.25/1.0)
- **App Store ID (iOS):** 1066720974
- **Bundle ID:** com.irpulsar.dementie
- **Performance Trend:** Stable
- **Data Window:** Analysis based on signals collected up to 2026-08-15

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** Dementie en herinneringen is a medical app for iOS that provides curated audio and visual stimuli to facilitate reminiscence therapy for individuals with dementia.
**Why users hire it:** Caregivers use the app to bridge communication gaps with patients by triggering positive memory recall, which helps maintain the patient's sense of identity and self-esteem.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Reminiscence Stimuli Library:** Curated collection of audio and visual fragments designed to trigger memory recall in dementia patients.
- **[Standard] Thematic Memory Modules:** Structured content themes focused on life events and achievements to improve patient self-esteem.
  * *User Intent:* Users value self-expression and personalized experiences.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

Dementie en herinneringen operates as a niche medical utility with no active monetization, reflecting its origin as a specialized support tool rather than a commercial product.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Free
- **Tiers:** Free
- **Analysis:** The app is listed as free with no observable in-app purchases or subscription gates.

<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- Curated reminiscence library provides specialized therapeutic value

**Growth Levers:**
- Personalized photo upload loop would increase engagement


<!-- /section:swot -->
## Recent Changes (v2 → v3) {#recent-changes}

Market positioning has pivoted to characterize the app as a specialized, non-commercial support tool, while the outlook now emphasizes technical debt and the risk of OS incompatibility over general market competition.

**Overall trend**: Stable
**Compared at**: 2026-08-15

### Medium-impact changes
- **[Shifted] Commercial Positioning Pivot** (positioning)
- **[Shifted] Refined Risk Assessment** (swot)

### Low-impact changes
- **[Shifted] Trend Classification** (outlook)

<!-- section:whats-new -->
## What's New

- **Latest (v5.0.1, 11 months ago):** Minor maintenance updates and general refinements.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Zombie) {#momentum}

- Quiet 11 months, no feature updates.
- Last major release 350 days ago.

> **Cadence:** 1 total versions · 0 majors in last 6 months · 350 days since last update

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

Dementie en herinneringen is a medical app that is completely free.

<!-- speakable-start -->
> **Bottom Line:** Maintaining the current static library without updates risks obsolescence as OS standards evolve, so the developer should consider an open-source transition or a minimal maintenance sprint to secure the existing user base.
<!-- speakable-end -->

**Best for:** Healthcare professionals, informal caregivers, and family members supporting individuals with dementia.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [MAINTAIN] Audit OS compatibility because the 350-day update gap risks app failure → maintain core utility
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Stable

The digital health market for dementia care is shifting toward integrated platforms that combine reminiscence with daily activity tracking. Dementie en herinneringen remains a static utility, which limits its long-term relevance as caregivers increasingly demand tools that offer broader support beyond simple memory triggers.

- ⚪ The 350-day update gap indicates a maintenance-only posture, which limits the potential for new feature expansion or user growth.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Total Reviews | 0 |
| Confidence | Low |
| Pricing Model | Free |
| Platforms | iOS |
| Key Features | 2 analyzed |
| Trend | Stable |
| Outlook | Stable |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **Dementie en herinneringen** (this app) | N/A/5 | N/A | Amulet BV |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** Amulet BV
- **Website:** [https://www.amulet.nl/](https://www.amulet.nl/)
- **Social:** [LinkedIn](https://www.linkedin.com/in/wiert)

## Data Sources & Links
- **App Store ID:** 1066720974
- **Dev Site:** [Official Website](https://www.amulet.nl/)
- **Sources:** Developer website content, About us / company information, App store metadata.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating
- [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.25/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 0
- **Data Sources:** developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 86 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/dementie-en-herinneringen)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.